Round-up: industry views on Bilski
30 June 2010
Managing Intellectual Property
From biotechnology to computers, industry leaders are having their say on the Bilski decision. Here are a few statements to note
Marshall Phelps, former IBM and Microsoft IP head: "My concern was that the pressure to do something about business methods would bleed over into software. I view it as a big sigh of relief on that point. The Court was smart enough to realise that they can't predict where technology is going to go. I think we're all going to live to see another day."
Jim Greenwood, Biotechnology Industry Organization: "The Court was clearly conscious of the potential negative and unforeseeable consequences of a broad and sweeping decision. This ruling specifically states that the 'machine-or-transformation test is not the sole test for patent eligibility' and recognised that the lower court's ruling could have created uncertainty in fields such as advanced diagnostic medicine techniques."
Daniel...
Only subscribers have complete access to Managing IP Magazine,
log in or
subscribe now.
Alternatively take a
free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial